Chronic alcohol exposure sensitizes mice to galactosamine-induced liver injury through enhanced keratinocyte chemoattractant and defective IL-10 production

Journal of Hepatology

Volumn 39, Issue 1, 2003, Pages 68-76

  Sermon, Filip ^a   Le Moine, Olivier ^a   Gustot, Thierry ^a   Quertinmont, Eric ^a   Louis, Hubert ^a   Nagy, Nathalie ^a   Degraef, Chantal ^a   Devière, Jacques ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Alcohol; Cytokines; Galactosamine; Liver; Mice

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; CENTRAL DEPRESSANT AGENT; CHEMOATTRACTANT; CYTOKINE; GALACTOSAMINE; INTERLEUKIN 10; KERATINOCYTE CHEMOATTRACTANT; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER DISEASE; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLOGY; DRUG INTERACTION; ENZYME RELEASE; FEMALE; HEPATITIS; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; INTESTINE; INTESTINE FLORA; KERATINOCYTE; LIVER INJURY; LIVER LEVEL; LIVER PROTECTION; LONG TERM EXPOSURE; METABOLISM; MICROBIOLOGY; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIZATION;

EID: 0037973483     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00186-7     Document Type: Article

References (43)

1. McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989;9:349-51.
2. Devière J, Content J, Denys C, Vandenbussche P, Schandené L, Wybran J, et al. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in alcoholic cirrhosis. Hepatology 1990;11:628-34.
3. Devière J, Content J, Denys C, Vandenbussche P, Schandené L, Wybran J, et al. High interleukin-6 serum levels and increased production by leukocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokine production. Clin Exp Immunol 1989;77:221-5.
4. Bird GLA, Sheron N, Goka AKJ, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990;112:917-20.
5. Sheron N, Bird GLA, Koskinas J, Portmann B, Ceska M, Lindley I, et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 1993;18:41-6.
6. Hill DB, Marsano LS, McClain CJ. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology 1993;18:576-80.
7. Mathurin P, Ganne-Carrie N, Poynard T, Trinchet JC. Proinflammatory cytokines in the pathogenesis of alcoholic hepatitis. Gastroenterol Clin Biol 1998;22:311-9.
8. Thurman II RG. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 1998;275:G605-11.
9. Nolan JP. Intestinal endotoxins as mediators of hepatic injury - an idea whose time has come again. Hepatology 1989;10:887-91.
10. Tamai H, Kato S, Horie Y, Ohki E, Yokoyama H, Ishii H. Effect of acute ethanol administration on the intestinal absorption of endotoxin in rats. Alcohol Clin Exp Res 2000;24:390-4.
11. Mathurin P, Deng QG, Keshavarzian A, Choudhary S, Holmes EW, Tsukamoto H. Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 2000;32:1008-17.
12. Parlesak A, Schafer C, Schutz T, Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 2000;32:742-7.
13. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995;108:218-24.
14. Adachi Y, Bradford BU, Gao W, Bojes HK, Thurman RG. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 1994;20:453-60.
15. Decker K, Keppler D. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol 1974;77-106.
16. Galanos C, Freudenberg MA, Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 1979;76:5939-43.
17. Hishinuma I, Nagakawa J, Hirota K, Miyamoto K, Tsukidate K, Yamanaka T, et al. Involvement of tumor necrosis factor-α in development of hepatic injury in galactosamine sensitized mice. Hepatology 1990;12:1187-91.
18. Kono H, Uesugi T, Froh M, Rusyn I, Bradford BU, Thurman RG. ICAM-1 is involved in the mechanism of alcohol-induced liver injury: studies with knockout mice. Am J Physiol Gastrointest Liver Physiol 2001;280:G1289-95.
19. Kono H, Rusyn I, Yin M, Gabele E, Yamashina S, Dikalova A, et al. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest 2000;106:867-72.
20. Uesugi T, Froh M, Arteel GE, Bradford BU, Thurman RG. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 2001;34:101-8.
21. Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 1999;117:942-52.
22. Gavrieli Y, Sherman Y, Ben Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
23. Rumpelt HJ. Ultrastructure of alcoholic hyalin and fate of the affected hepatocytes. Virchows Arch B Cell Pathol 1977;23:339-51.
24. Cao Q, Batey R, Pang G, Clancy R. Ethanol-altered liver-associated T cells mediate liver injury in rats administered Concanavalin A (Con A) or lipopolysaccharide (LPS). Alcohol Clin Exp Res 1999;23:1660-7.
25. Tsukamoto H, Lu SC. Current concepts in the pathogenesis of alcoholic liver injury. FASEB J 2001;15:1335-49.
26. Goldin RD, Wickramasinghe SN. Hepatotoxicity of ethanol in mice. Br J Exp Pathol 1987;68:815-24.
27. Moore KW, de Waal MR, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
28. Le Moine O, Marchant A, De Groote D, Azar C, Goldman M, Devière J. Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholic cirrhosis. Hepatology 1995;22:1436-9.
29. Llorent L, Richaud-Patin Y, Alcocer-Castillejos N, Ruiz-Soto R, Mercado MA, Orozco H, et al. Cytokine gene expression in cirrhotic and non-cirrhotic human liver. J Hepatol 1996;24:555-63.
30. Nanji AA, Jokelainen K, Rahemtulla A, Miao L, Fogt F, Matsumoto H, et al. Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 1999;30:934-43.
31. Seitz M, Loetscher P, Dewald B, Towbin H, Gallati H, Baggiolini M. Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur J Immunol 1995;25:1129-32.
32. Kim HS, Armstrong D, Hamilton TA, Tebo JM. IL-10 suppresses LPS-induced, KC mRNA expression via a translation-dependent decrease in mRNA stability. J Leukoc Biol 1998;64:33-9.
33. Lira SA, Zalamea P, Heinrich JN, Fuentes ME, Carrasco D, Lewin AC, et al. Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells. J Exp Med 1994;180:2039-48.
34. Bozic CR, Kolakowski Jr LF, Gerard NP, Garcia-Rodriguez C, Uexkull-Guldenband C, Conklyn MJ, et al. Expression and biologic characterization of the murine chemokine KC. J Immunol 1995;154:6048-57.
35. Kunkel, S.L., Lukacs, N.W., Kasama, T., and Strieter, R.M. (1994) Chemotactic cytokines. In: Griffin G.E, editor. Cytokines in infection. Balliere Tindall: London, 1994. p. 25-36
36. Devalaraja MN, McClain CJ, Barve S, Vaddi K, Hill DB. Increased monocyte MCP-1 production in acute alcoholic hepatitis. Cytokine 1999;11:875-81.
37. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, et al. Plasma tumor necrosis factor-α predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 1990;14:255-9.
38. Nanji AA, Zhao S, Sadrzadeh SM, Waxman DJ. Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology 1994;19:1483-7.
39. Perez C, Albert I, DeFay K, Zachariades N, Gooding L, Kriegler M. A non secretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 1990;63:251-8.
40. Grell M, Douni E, Wajant H, Lohden M, Claus M, Maxeiner B, et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kD tumor necrosis factor receptor. Cell 1995;83:793-802.
41. Chojkier M, Fierer J. D-Galactosamine hepatotoxicity is associated with endotoxin sensitivity and mediated by lymphoreticular cells in mice. Gastroenterology 1985;88:115-21.
42. Madsen KL, Doyle JS, Tavernini MM, Jewell LD, Rennie RP, Fedorak RN. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 2000;118:1094-105.
43. Cabre E, Rodriguez-Iglesias, Caballeria J, Quer JC, Sanchez-Lombrana JL, Pares A, Planas R, et al. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology 2000;32:36-42.